日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Perineural invasion and risk of lymph node metastasis in early-stage operable breast cancer: a large-scale propensity-matched cohort study and meta-analysis

早期可手术乳腺癌中神经周围侵犯与淋巴结转移风险:一项大规模倾向性匹配队列研究和荟萃分析

Cai, Weifeng; Wang, Yali; Qiu, Yibin; He, Peng; Cai, Qindong; Liu, Shunyi; Zhan, Jiaqi; Chen, Minyan; Chen, Lili; Xu, Chunsen; Lin, Shunguo; Fu, Fangmeng; Wang, Chuan

The role of infraclavicular and supraclavicular lymph nodes in breast cancer patients receiving neoadjuvant chemotherapy: implications for regional lymph node classification

锁骨下和锁骨上淋巴结在接受新辅助化疗的乳腺癌患者中的作用:对区域淋巴结分类的意义

Chen, Yanyu; Song, Yuzhi; Han, Zhonghua; Han, Hui; Tang, Tianlan; Chen, Silin; Zhao, Ruizhi; Huang, Cheng; Shi, Guiqing; Lin, Yuping; Wang, Ying; Jiang, Liuqing; Chen, Jinhua; Xu, Chunsen; Fu, Fangmeng; Wang, Chuan; Yang, Yong

Multi-cancer early detection based on serum surface-enhanced Raman spectroscopy with deep learning: a large-scale case-control study

基于血清表面增强拉曼光谱和深度学习的多癌种早期检测:一项大规模病例对照研究

Lin, Yuxiang; Zhang, Qiyi; Chen, Hanxi; Liu, Shuhang; Peng, Kaiming; Wang, Xiaojie; Zhang, Liyong; Huang, Jun; Yan, Xiuqing; Lin, Xueliang; Hasan, Uddin M D; Sarwara, Mahabub; Fu, Fangmeng; Feng, Shangyuan; Wang, Chuan

Effect of a machine learning prediction model on the false-negative rate of sentinel lymph node biopsy for clinically node-positive breast cancer after neoadjuvant chemotherapy

机器学习预测模型对新辅助化疗后临床淋巴结阳性乳腺癌前哨淋巴结活检假阴性率的影响

Chen, Minyan; Hong, Tianzi; Wang, Yali; Li, Shengmei; Zeng, Bangwei; Chen, Cong; Zhang, Jie; Guo, Wenhui; Chen, Lili; Lin, Yuxiang; Wang, Chuan; Fu, Fangmeng

Prognostic value of nuclear features based on tumor-associated collagen signatures in breast cancer

基于肿瘤相关胶原蛋白特征的核特征在乳腺癌预后中的价值

Li, Zhijun; Kang, Deyong; Wang, Chuan; Ma, Jianli; Zhang, Shichao; Xi, Gangqin; Li, Lianhuang; Zheng, Liqin; Guo, Wenhui; Fu, Fangmeng; Zhang, Qingyuan; Qiu, Lida; Han, Xiahui; Xu, Shunwu; Chen, Jianhua; Xu, Shuoyu; Chen, Jianxin

Clinical TP53 genetic testing is recommended for HER2-positive breast cancer patients aged 35 or younger

建议对35岁及以下的HER2阳性乳腺癌患者进行TP53基因临床检测。

Li, Jing; Chen, Lili; Chen, Xuhui; Huang, Meng; Guo, Wenhui; Chen, Minyan; Lin, Yuxiang; Wang, Yali; Cai, Weifeng; Qiu, Yibin; He, Peng; Cai, Qindong; Wang, Chuan; Fu, Fangmeng

Toripalimab plus gemcitabine and cisplatin induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective study

托瑞普利单抗联合吉西他滨和顺铂诱导化疗治疗局部晚期鼻咽癌:一项回顾性研究

Liang, Renba; Lei, Ling; Li, Xinxiao; Lan, Fengming; Fu, Fangmeng; Zou, Teng; Ma, Li; Chen, Peng; Wang, Zhanmei; Jin, Jing; Zhang, Jianghu

Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer

早期乳腺癌中程序性细胞死亡通路基因3'非翻译区多态性的额外预后价值

Chen, Hanxi; Chen, Minyan; Zeng, Bangwei; Tang, Lili; Nie, Qian; Jin, Xuan; Guo, Wenhui; Chen, Lili; Lin, Yuxiang; Wang, Chuan; Fu, Fangmeng

Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study

HER2阳性乳腺癌炎症血液标志物与病理完全缓解的相关性:一项回顾性单中心队列研究

Chen, Xiaobin; Cai, Qindong; Deng, Lin; Chen, Minyan; Xu, Min; Chen, Lili; Lin, Yuxiang; Li, Yan; Wang, Yali; Chen, Hanxi; Liu, Shunyi; Wu, Jinqiao; Tong, Xin; Fu, Fangmeng; Wang, Chuan

Prognostic significance of collagen signatures at breast tumor boundary obtained by combining multiphoton imaging and imaging analysis

结合多光子成像和成像分析获得的乳腺肿瘤边界胶原蛋白特征的预后意义

Huang, Xingxin; Fu, Fangmeng; Guo, Wenhui; Kang, Deyong; Han, Xiahui; Zheng, Liqin; Zhan, Zhenlin; Wang, Chuan; Zhang, Qingyuan; Wang, Shu; Xu, Shunwu; Ma, Jianli; Qiu, Lida; Chen, Jianxin; Li, Lianhuang